User profiles for Alan Winston

Alan Winston

Verified email at imperial.ac.uk
Cited by 11321

[HTML][HTML] Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical …

…, P Goulder, P Klenerman, GR Screaton, A Winston… - The lancet HIV, 2021 - thelancet.com
Background Data on vaccine immunogenicity against SARS-CoV-2 are needed for the 40
million people globally living with HIV who might have less functional immunity and more …

British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in …

…, J Walsh, L Waters, E Wilkins, A Winston… - HIV …, 2014 - Wiley Online Library
British HIV Association guidelines for the treatment of <fc>HIV</fc>â•’1â•’positive adults with
antiretrov Page 1 British HIV Association guidelines for the treatment of HIV-1-positive …

Controversies in HIV-associated neurocognitive disorders

S Nightingale, A Winston, S Letendre… - The Lancet …, 2014 - thelancet.com
Cross-sectional studies show that around half of individuals infected with HIV-1 have some
degree of cognitive impairment despite the use of antiretroviral drugs. However, prevalence …

Transmission of monkeypox virus through sexual contact–A novel route of infection

…, N Mughal, T Rampling, A Winston… - Journal of …, 2022 - journalofinfection.com
We read with interest the article published in this journal by Pezzati et al. on the use of rapid
lateral flow assays to detect antibodies induced by vaccination against SARS-CoV-2 …

[HTML][HTML] Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort …

…, N Mackie, L Garvey, A Winston… - The Lancet Infectious …, 2023 - thelancet.com
Background The scale of the 2022 global mpox (formerly known as monkeypox) outbreak
has been unprecedented. In less than 6 months, non-endemic countries have reported more …

Increased brain-predicted aging in treated HIV disease

…, C Franceschi, CA Sabin, CBLM Majoie, A Winston… - Neurology, 2017 - AAN Enterprises
Objective: To establish whether HIV disease is associated with abnormal levels of age-related
brain atrophy, by estimating apparent brain age using neuroimaging and exploring …

Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program

…, L Sherr, A Streinu-Cercel, A Winston… - Clinical Infectious …, 2013 - academic.oup.com
Many practical clinical questions regarding the management of human immunodeficiency
virus (HIV)–associated neurocognitive disorder (HAND) remain unanswered. We sought to …

[HTML][HTML] Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

…, S Faust, H Hassanin, CA Cosgrove, A Winston… - …, 2022 - thelancet.com
Background Lipid nanoparticle (LNP) encapsulated self-amplifying RNA (saRNA) is a novel
technology formulated as a low dose vaccine against COVID-19. Methods A phase I first-in-…

Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled …

…, BG Gazzard, IG Williams, MJ Fisher, A Winston… - Jama, 2012 - jamanetwork.com
Context Therapies to decrease immune activation might be of benefit in slowing HIV disease
progression. Objective To determine whether hydroxychloroquine decreases immune …

Major revision version 11.0 of the European AIDS clinical society guidelines 2021

…, JM Molina, JD Kowalska, G Guaraldi, A Winston… - HIV …, 2022 - Wiley Online Library
Background The European AIDS Clinical Society (EACS) Guidelines were revised in 2021
for the 17th time with updates on all aspects of HIV care. Key points of the Guidelines update …